GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...

So-called GLP-1 supplements, named to echo the class of glucagon-like peptide-1 agonist drugs that includes ... Still, the metabolic mechanism the supplements claim to achieve — boosting natural ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...

The Monell team and colleagues identified that GLP-1 receptor agonists, a class of drugs currently used ... suggesting a different mechanism for weight gain compared to typical obesity animal models.

Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with ...

Among US adults without diabetes, the use of GLP-1 RAs increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

However, emerging research suggests that glucagon-like peptide-1 (GLP-1) receptor agonists—commonly ... with AI ∙ DALL-E image Creator Mechanism of Action Relevant to AUD GLP-1 is an incretin ...